Response Modifiers: Tweaking the Immune Response Against Influenza A Virus

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Influenza A virus (IAV) causes significant global morbidity and mortality.
• Current treatments like vaccines and antivirals face challenges due to reduced efficacy in vulnerable populations and drug resistance.
• IAV relies on host factors for replication, presenting potential therapeutic targets.

Purpose of the Study:

• To review the therapeutic potential of biological response modifiers (BRMs) against IAV infections.
• To explore how BRMs can modulate host immune responses to combat IAV.
• To assess the repurposing of existing BRMs for accelerated use against severe influenza.

Main Methods:

• Literature review of existing research on IAV, host-virus interactions, and BRMs.
• Analysis of different classes of BRMs and their mechanisms of action.
• Discussion of the potential application of BRMs in treating influenza.

Main Results:

• IAV's reliance on host factors offers alternative therapeutic targets.
• BRMs, including antibodies and small molecules, can modulate immune responses.
• Repurposing clinical BRMs could expedite treatment for severe influenza.

Conclusions:

• Targeting host-virus interactions and modulating immune responses with BRMs are promising strategies for IAV treatment.
• BRMs offer a potential alternative or adjunct to existing therapies for influenza A virus infections.
• Further research into BRM classes could lead to novel interventions against influenza.